Elinor Lee is a Respiratory physician affiliated with University of California, Los Angeles. OpenAlex indexes 43 publications with 1,747 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Medical Plaza Suite 365 B
Los Angeles, CA 900953411
Telephone
310-825-7921Registry record last updated 27 Jun 2019.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Partner Therapeutics, Inc.Program year20241 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
- Partner Therapeutics, Inc.Program year20234 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
100%Corticosteroid43.7%Fluticasone Propionate66%Breyna34%Part D<11 patientsbeta2-Adrenergic Agonist40.2%Albuterol Sulfate Hfa100%Part D≥16 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Role of GM-CSF and impaired lipid metabolism in the pathogenesis of PAP
University of California Los Angeles
FY2026$170,532K08HL166970 - Role of GM-CSF and impaired lipid metabolism in the pathogenesis of PAP
University of California Los Angeles
FY2025$170,532K08HL166970 - Role of GM-CSF and impaired lipid metabolism in the pathogenesis of PAP
University of California Los Angeles
FY2024$170,532K08HL166970
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Synthesis, Purification, and Characterization of Precursors for Pt-HDACi Adducts as Bifunctional Anticancer Agents
Scholarly Commons (University of the Pacific)
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Jerome Engel, MD
University of California, Los Angeles
Fernando Martinez, MD
University of Massachusetts Chan Medical School
David Gozal, MD
Ronald Crystal, MD
Weill Cornell Medicine
Bartolome Celli, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”